Literature DB >> 17340199

Brief report: aggression and stereotypic behavior in males with fragile X syndrome--moderating secondary genes in a "single gene" disorder.

David Hessl1, Flora Tassone, Lisa Cordeiro, Kami Koldewyn, Carolyn McCormick, Cherie Green, Jacob Wegelin, Jennifer Yuhas, Randi J Hagerman.   

Abstract

Although fragile X syndrome (FXS) is a single gene disorder with a well-described phenotype, it is not known why some individuals develop more significant maladaptive behaviors such as aggression or autistic symptoms. Here, we studied two candidate genes known to affect mood and aggression, the serotonin transporter (5-HTTLPR) and monoamine oxidase A (MAOA-VNTR) polymorphisms, in 50 males with FXS ages 8-24 years. Mothers and fathers of participants reported the frequency and severity of aggressive/destructive, self-injurious, and stereotypic behaviors. Polymorphism genotypes were unrelated to age and IQ. Results showed a significant effect of 5-HTTLPR genotype on aggressive/destructive and stereotypic behavior; males with FXS who were homozygous for the high-transcribing long (L/L) genotype had the most aggressive and destructive behavior, and individuals homozygous for the short (S/S) genotype had the least aggression. Those with the L/L genotype also had the highest levels of stereotypic behavior. There was no effect of MAOA-VNTR on behavior; however those with the high-activity, 4-repeat genotype were more likely to be taking SSRI or SNRI medication. This preliminary study prompts consideration of secondary genes that may modify behavioral phenotype expression in neurodevelopmental disorders, even those with a single gene etiology such as FXS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340199     DOI: 10.1007/s10803-007-0365-5

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  45 in total

1.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

2.  Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome.

Authors:  F Tassone; R J Hagerman; D Garcia-Arocena; E W Khandjian; C M Greco; P J Hagerman
Journal:  J Med Genet       Date:  2004-04       Impact factor: 6.318

3.  Clinical efficacy of fluvoxamine and functional polymorphism in a serotonin transporter gene on childhood autism.

Authors:  Yoko Sugie; Hideo Sugie; Tokiko Fukuda; Masataka Ito; Yumiko Sasada; Mutsumi Nakabayashi; Kazunobu Fukashiro; Takehiko Ohzeki
Journal:  J Autism Dev Disord       Date:  2005-06

4.  The Behavior Problems Inventory: an instrument for the assessment of self-injury, stereotyped behavior, and aggression/destruction in individuals with developmental disabilities.

Authors:  J Rojahn; J L Matson; D Lott; A J Esbensen; Y Smalls
Journal:  J Autism Dev Disord       Date:  2001-12

5.  Possible association between serotonin transporter promoter region polymorphism and extremely violent crime in Chinese males.

Authors:  Ding-Lieh Liao; Chen-Jee Hong; Hao-Ling Shih; Shih-Jen Tsai
Journal:  Neuropsychobiology       Date:  2004       Impact factor: 2.328

6.  The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.

Authors:  D Devys; Y Lutz; N Rouyer; J P Bellocq; J L Mandel
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

7.  Association study of serotonin transporter gene VNTR polymorphism and mood disorders, onset age and suicide attempts in a Chinese sample.

Authors:  Feng-Chang Yen; Chen-Jee Hong; Sheu-Jane Hou; Jiunn-Kae Wang; Shih-Jen Tsai
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

8.  Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder.

Authors:  Deborah C Lawson; Darko Turic; Kate Langley; Helen M Pay; Catherine F Govan; Nadine Norton; Marian L Hamshere; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

9.  Serotonin transporter polymorphisms and measures of impulsivity, aggression, and sensation seeking among African-American cocaine-dependent individuals.

Authors:  Ashwin A Patkar; Wade H Berrettini; Margret Hoehe; Charles C Thornton; Edward Gottheil; Kevin Hill; Stephen P Weinstein
Journal:  Psychiatry Res       Date:  2002-06-01       Impact factor: 3.222

Review 10.  Psychopharmacology in fragile X syndrome--present and future.

Authors:  Elizabeth Berry-Kravis; Kristina Potanos
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004
View more
  36 in total

Review 1.  Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments.

Authors:  Jeremy Veenstra-VanderWeele; Randy D Blakely
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Change in the Behavioral Phenotype of Adolescents and Adults with FXS: Role of the Family Environment.

Authors:  Leann E Smith; Jinkuk Hong; Jan S Greenberg; Marsha R Mailick
Journal:  J Autism Dev Disord       Date:  2016-05

3.  Effect of sustained maternal responsivity on later vocabulary development in children with fragile X syndrome.

Authors:  Nancy Brady; Steven F Warren; Kandace Fleming; Juliana Keller; Audra Sterling
Journal:  J Speech Lang Hear Res       Date:  2014-02       Impact factor: 2.297

4.  Telehealth Delivery of Function-Based Behavioral Treatment for Problem Behaviors Exhibited by Boys with Fragile X Syndrome.

Authors:  Katerina D Monlux; Joy S Pollard; Arlette Y Bujanda Rodriguez; Scott S Hall
Journal:  J Autism Dev Disord       Date:  2019-06

5.  Emotion recognition and visual-scan paths in Fragile X syndrome.

Authors:  Tracey A Shaw; Melanie A Porter
Journal:  J Autism Dev Disord       Date:  2013-05

6.  Problem behaviour in adolescent boys with fragile X syndrome: relative prevalence, frequency and severity.

Authors:  S S Hall; R P Barnett; K M Hustyi
Journal:  J Intellect Disabil Res       Date:  2016-10-11

7.  FRAGILE X SYNDROME: PSYCHIATRIC MANIFESTATIONS, ASSESSMENT AND EMERGING THERAPIES.

Authors:  Paula M Wadell; Randi J Hagerman; David R Hessl
Journal:  Curr Psychiatry Rev       Date:  2013-02-01

8.  Aging in fragile X syndrome.

Authors:  Agustini Utari; Evan Adams; Elizabeth Berry-Kravis; Alyssa Chavez; Felicia Scaggs; Lily Ngotran; Antoniya Boyd; David Hessl; Louise W Gane; Flora Tassone; Nicole Tartaglia; Maureen A Leehey; Randi J Hagerman
Journal:  J Neurodev Disord       Date:  2010-05-12       Impact factor: 4.025

Review 9.  Genetics of autistic disorders: review and clinical implications.

Authors:  Christine M Freitag; Wouter Staal; Sabine M Klauck; Eftichia Duketis; Regina Waltes
Journal:  Eur Child Adolesc Psychiatry       Date:  2009-11-26       Impact factor: 4.785

10.  Fragile X and autism: Intertwined at the molecular level leading to targeted treatments.

Authors:  Randi Hagerman; Gry Hoem; Paul Hagerman
Journal:  Mol Autism       Date:  2010-09-21       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.